Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia

It is difficult to predict musculoskeletal pain as a withdrawal syndrome following the discontinuation of imatinib (IM) in patients with chronic myeloid leukemia. We investigated a link between physical size and musculoskeletal pain following IM discontinuation. In total, seven out of 24 patients de...

Descripción completa

Detalles Bibliográficos
Autores principales: Katagiri, Seiichiro, Tauchi, Tetsuzo, Ando, Keiko, Okabe, Seiichi, Gotoh, Moritaka, Ohyashiki, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402624/
https://www.ncbi.nlm.nih.gov/pubmed/28462083
http://dx.doi.org/10.1016/j.lrr.2017.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402624/
https://www.ncbi.nlm.nih.gov/pubmed/28462083
http://dx.doi.org/10.1016/j.lrr.2017.04.002

Ejemplares similares